Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis-associated protein 25 (SPATA25) is a testis-expressed protein believed to play a role in spermatogenesis. It is encoded by the SPATA25 gene, with documented expression in round spermatids and a postnatal expression pattern that increases in rodent models from day 15 to adulthood[5]. The protein is predicted to be membrane-associated but its molecular classification does not match typical drug or therapeutic target classes such as receptor, transporter, or enzyme[1][3][5][9]. SPATA25 has been genetically linked to male infertility syndromes such as azoospermia, though functional and mechanistic insights are limited. No drugs, biomarkers, or therapeutic interventions are currently associated with SPATA25—indicating its principal relevance is in basic research or as a genetic marker rather than a clinical target[1][3][5][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 25 (SPATA25).